Preserve Access to Affordable Generics and Biosimilars Act | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

449,169 results for “Preserve Access to Affordable Generics and Biosimilars Act”

Senate Judiciary Committee Advances Six Bipartisan Bills to Combat High Drug Prices

California's AB 824 Pharmaceutical Patent Settlement Law Faces Permanent Injunction Limiting Enforcement

Senate HELP Committee Advances Two Biosimilar Reform Bills to Accelerate Patient Access to Lower-Cost Medicines

Generic Drug Industry Transformation: Biosimilars and Complex Generics Drive New Growth for Sandoz, Teva, and Viatris

2025 Pharmaceutical Pipeline: Major Patent Expirations Set to Transform Drug Market with Generics and Biosimilars

Zentiva Launches First Biosimilar Monoclonal Antibody Across EU Markets

Pakistan Approves Chinese Biosimilar Cancer Drug to Expand Access to Affordable Bevacizumab Treatment

Biocon Biologics and Civica Partner to Increase Affordable Insulin Aspart Access in US Market

India-UK Free Trade Agreement Raises Concerns Over Access to Affordable Medicines

Inflation Reduction Act to Lower BTK Inhibitor Costs, Potentially Transforming CLL and MCL Treatment Access

Page 1 of 4083